연구성과로 돌아가기
2023 연구성과별 연구자 정보 (1805 / 2675)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | Cho, Hee Jin | Cho, HJ | 7 | Kyungpook Natl Univ, Sch Convergence, Dept Biomed Convergence Sci & Technol, Daegu, South Korea | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | |||||
| Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | Cho, Hee Jin | Cho, HJ | 7 | Kyungpook Natl Univ, Cell & Matrix Res Inst, Daegu, South Korea | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | |||||
| Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | Mu, Quanhua | Mu, QH | 8 | Hong Kong Univ Sci & Technol, Dept Chem & Biol Engn, Kowloon, Clear Water Bay, Hong Kong, Peoples R China | JKI-6568-2023 | Mu, Quanhua | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | |||
| Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | Choi, Seung Won | Choi, SW | 9 | Columbia Univ, Dept Syst Biol, Program Math Genom, New York, NY USA | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | |||||
| Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | Sa, Jason K. | Sa, JK | 10 | Korea Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea | 0000-0002-3251-5004 | Sa, Jason Kyungha | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | |||
| Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | Seo, Yun Jee | Seo, YJ | 11 | Samsung Med Ctr, Inst Refractory Canc Res, Res Inst Future Med, Seoul, South Korea | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | |||||
| Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | Kim, Yejin | Kim, Y | 12 | Samsung Med Ctr, Inst Refractory Canc Res, Res Inst Future Med, Seoul, South Korea | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | |||||
| Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | Lee, Kyoungmin | Lee, K | 13 | Samsung Med Ctr, Inst Refractory Canc Res, Res Inst Future Med, Seoul, South Korea | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | |||||
| Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | Oh, Jeong-Woo | Oh, JW | 14 | Samsung Med Ctr, Inst Refractory Canc Res, Res Inst Future Med, Seoul, South Korea | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | |||||
| Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | Kwon, Yong-Jun | Kwon, YJ | 15 | Samsung Med Ctr, Inst Refractory Canc Res, Res Inst Future Med, Seoul, South Korea | 0000-0002-7249-3014 | Kwon, Yong-Jun | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | |||
| Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | Park, Woong-Yang | Park, WY | 16 | Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | |||||
| Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | Park, Woong-Yang | Park, WY | 16 | Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | |||||
| Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | Kong, Doo-Sik | Kong, DS | 17 | Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | |||||
| Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | Kong, Doo-Sik | Kong, DS | 17 | Sungkyunkwan Univ, Sch Med, Seoul, South Korea | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | |||||
| Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | Seol, Ho Jun | Seol, HJ | 18 | Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; |
페이지 이동: